Indapamide Doc Generici (Indapamide)

Indapamide inhibits the sodium‑chloride cotransporter in the distal convoluted tubule of the kidney. This action reduces reabsorption of sodium and chloride, leading to increased urinary loss of water and electrolytes. The resulting decrease in plasma volume and peripheral vascular resistance contributes to lower blood pressure.

The specific dose of indapamide is determined by the prescribing healthcare professional based on the individual’s medical condition, response to therapy, and other factors. Patients should follow the prescriber’s instructions and not adjust the dose without medical guidance.

Indapamide is classified as Pregnancy Category B, indicating that animal studies have not shown risk but there are no adequate controlled studies in pregnant women. It should be used only if clearly needed. Limited data are available for breastfeeding; the prescriber should weigh potential benefits against risks.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Indapamide is a thiazide‑like diuretic, offering a longer duration of action and a more favorable metabolic profile compared with classic thiazides such as hydrochlorothiazide. It provides effective blood‑pressure reduction with a lower incidence of certain electrolyte disturbances, making it a preferred option for many clinicians.

Indapamide Doc Generici should be stored at ambient temperature, preferably below 25 °C. Keep the tablets in the original container, protect them from moisture, heat, and direct sunlight to maintain stability and potency throughout the shelf life.

Indapamide Doc Generici is taken orally, usually once daily in the morning with or without food, as directed by the prescriber. Swallow the tablet whole with a glass of water; do not crush or chew unless specifically instructed.

Serious risks include severe dehydration, significant electrolyte imbalances such as hypokalemia or hyponatremia, and rare allergic reactions that may manifest as rash, swelling, or difficulty breathing. Patients should be monitored regularly for these conditions, especially during the initial treatment phase.

Indapamide is contraindicated in patients with anuria, severe renal impairment, or known hypersensitivity to the drug or other thiazide‑like diuretics. Caution is also advised for individuals with uncontrolled diabetes, gout, or those taking lithium, as the medication may exacerbate these conditions.